Analyst Ratings For Amgen (NASDAQ:AMGN)
Today, BMO Capital Markets reiterated its Buy rating on Amgen (NASDAQ:AMGN) with a price target of $199.00.
There are 11 hold ratings, 11 buy ratings, 1 strong buy rating on the stock.
The current consensus rating on Amgen (NASDAQ:AMGN) is Buy (Score: 2.57) with a consensus target price of $185.68 per share, a potential 3.04% upside.
Some recent analyst ratings include
- 7/21/2017-BMO Capital Markets Reiterated Rating of Buy.
- 7/17/2017-Jefferies Group LLC Reiterated Rating of Buy.
- 7/14/2017-Oppenheimer Holdings, Inc. Reiterated Rating of Outperform.
- 7/10/2017-Morgan Stanley Reiterated Rating of Overweight.
- 7/9/2017-Mizuho Reiterated Rating of Buy.
- 6/26/2017-William Blair Reiterated Rating of Market Perform.
Dividend information for Amgen (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) pays an annual dividend of Community Ranking: with a yield of 2.55% and an average dividend growth of 28.60% based on a 3 Year Average.
Dividend History for Amgen (NASDAQ:AMGN)
- On 3/7/2017 Amgen announced a quarterly dividend of $1.15 2.59% with an ex dividend date of 5/15/2017 which will be payable on 6/8/2017.
- On 12/20/2016 Amgen announced a quarterly dividend of $1.15 3.15% with an ex dividend date of 2/13/2017 which will be payable on 3/8/2017.
- On 10/14/2016 Amgen announced a quarterly dividend of $1.00 2.46% with an ex dividend date of 11/14/2016 which will be payable on 12/8/2016.
- On 7/22/2016 Amgen announced a quarterly dividend of $1.00 2.4% with an ex dividend date of 8/15/2016 which will be payable on 9/8/2016.
- On 3/2/2016 Amgen announced a quarterly dividend of $1.00 2.74% with an ex dividend date of 5/13/2016 which will be payable on 6/8/2016.
- On 12/15/2015 Amgen announced a quarterly dividend of $1.00 2.43% with an ex dividend date of 2/11/2016 which will be payable on 3/8/2016.
- On 10/14/2015 Amgen announced a quarterly dividend of $0.79 2.07% with an ex dividend date of 11/12/2015 which will be payable on 12/7/2015.
Recent Insider Trading Activity For Amgen (NASDAQ:AMGN)
Amgen (NASDAQ:AMGN) has insider ownership of 0.20% and institutional ownership of 78.80%.
- On 5/24/2017 Cynthia M Patton, SVP, sold 2,922 with an average share price of $154.40 per share and the total transaction amounting to $451,156.80. View SEC Filing
- On 8/2/2016 Annette Louise Such, VP, sold 3,000 with an average share price of $174.59 per share and the total transaction amounting to $523,770.00. View SEC Filing
- On 5/4/2016 Madhavan Balachandran, EVP, sold 30,000 with an average share price of $154.12 per share and the total transaction amounting to $4,623,600.00. View SEC Filing
- On 4/29/2016 David Baltimore, Director, sold 3,312 with an average share price of $157.21 per share and the total transaction amounting to $520,679.52. View SEC Filing
- On 4/29/2016 Sean E Harper, EVP, sold 21,875 with an average share price of $157.99 per share and the total transaction amounting to $3,456,031.25. View SEC Filing
- On 8/31/2015 Carbonnel Francois De, Director, sold 5,000 with an average share price of $153.84 per share and the total transaction amounting to $769,200.00. View SEC Filing
- On 8/19/2015 Fred Hassan, Director, bought 3,010 with an average share price of $166.63 per share and the total transaction amounting to $501,556.30. View SEC Filing
Recent Trading Activity for Amgen (NASDAQ:AMGN)
Shares of Amgen closed the previous trading session at 180.21 up +0.89 0.50% with 2,674,714 shares trading hands.